Rubric Capital Management LP
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1687509
NEW YORK, NY
Position in INDV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,193,457
New position
Shares Held
662,515
first reported quarter
Ownership
0.543%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $1,294,593,148 across 7 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
15,250,000 | $459,330,000 | |
| 2 | VTRS |
Viatris Inc
|
33,500,000 | $452,585,000 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,750,000 | $180,562,500 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
11,037,589 | $137,197,231 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
1,279,611 | $42,316,735 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
662,515 | $20,193,457 | |
| 7 | TXMD |
TherapeuticsMD, Inc.
|
1,192,191 | $2,408,225 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,193,457 | 662,515 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||